Labiotech.eu

In Depth 14 Jan 2020

What’s the Secret to Making Returns in Industrial Biotech?

As industrial biotech starts gaining more and more traction, investors need to change their mindset in order to start making returns in this promising field. Microorganisms have been helping us make food and drink since ancient times. Thanks to the industrial biotech revolution, these microbes could soon be responsible for manufacturing anything from clothing to […]

January 14, 2020 - 3 minutesmins - By Clara Rodríguez Fernández

kandy therapeutics menopause treatment brain

News and Trends 13 Jan 2020

KaNDy’s Menopause Treatment Tackles Hot Flashes in Phase II

A non-hormonal menopause treatment that targets the brain’s ‘thermostat’, developed by the UK company KaNDy Therapeutics, has significantly reduced hot flashes and improved quality of life in postmenopausal women in a phase IIb trial. The 199 women recruited into the study were experiencing a minimum of seven hot flashes per day. After 12 weeks of […]

January 13, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 10 Jan 2020

Eyevensys’ Gene Therapy for Blindness Boosted with €27M Series B

The French company Eyevensys has raised €27M to fund the launch of a phase II trial for its lead candidate, a non-viral gene therapy for an eye condition called uveitis that can lead to blindness. The Series B round was led by the Boehringer Ingelheim Venture Fund. New investors to Eyevensys in this round included […]

January 10, 2020 - 3 minutesmins - By Jonathan Smith

Startup Scout 10 Jan 2020

This Biotech Makes Easily Implantable Artificial Cornea Transplants

CorNeat Vision, based in Israel, is developing an easily-implantable and affordable artificial cornea that could one day replace donor corneas in people needing transplants and therefore address the shortage of donor tissue. Mission: To develop a cornea made from plastic that is easier to supply and implant than donor corneas. The implant is also designed […]

January 10, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 9 Jan 2020

Emergex Vaccines Secures €10M to Advance Synthetic Vaccine Development

The UK biotech Emergex Vaccines has raised over €9.9M in a Series A funding round, which will allow it to progress the development of vaccines against diseases such as dengue, influenza, and Ebola to phase I clinical trials. Emergex specializes in the development of ‘set-point’ vaccines, which company CEO and co-founder Thomas Rademacher describes as […]

January 9, 2020 - 3 minutesmins - By External Contributor

tumor cancer immunotherapy alderaan biotech

News and Trends 9 Jan 2020

French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy

Alderaan Biotechnology has raised an €18.5M Series A round to push its lead cancer immunotherapy drug to phase I. The UK VC firm Medicxi and the returning French VC investor Advent France Biotechnology contributed to the round. Alderaan, whose name was inspired by a fictional planet in the Star Wars movies, will use part of […]

January 9, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 8 Jan 2020

Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment

The founders of Swiss biotech Therachon have launched a new company called VectivBio, also based in Basel, with €31M funding to develop drugs for rare diseases. The spin-out comes after Therachon was acquired by Pfizer last year in a deal worth up to €700M. Therachon’s CEO, CBO, CFO and CMO will all move to the […]

January 8, 2020 - 2 minutesmins - By Helen Albert

nash northsea therapeutics, liver disease, disease modeling

News and Trends 8 Jan 2020

NorthSea Therapeutics Raises €36M to Complete NASH Phase II Trial

The Dutch biotech NorthSea Therapeutics has raised a €36M ($40M) Series B round to fund the end of a phase IIb trial of its lead fatty acid drug to treat the liver condition NASH, as well as advancing two other drugs to clinical trials. There were two newcomers to the round: the US investor venBio […]

January 8, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 7 Jan 2020

Update: Chinese Pharma Enlists Synaffix’s ADC Technology for Second Drug

Update (07/01/2020): Shanghai Miracogen has expanded its pre-existing license agreement with the Dutch biotech Synaffix. Under the terms of the new agreement, the Chinese pharma will use Synaffix’s antibody-drug conjugate technology to develop a second drug for the treatment of cancer. No financial details were disclosed. Published 10/04/2019: Shanghai Miracogen will pay up to €111M […]

January 7, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 7 Jan 2020

AstraZeneca Recruits RNA Biotech to Develop Metabolic Disease Therapies

The UK biotech MiNA Therapeutics has launched a collaboration with AstraZeneca to develop small activating RNA drugs, which could treat metabolic diseases using targets unreachable by current medications. According to the agreement, the two partners will carry out preclinical research with the aim of generating candidate drugs based on small activating RNA, or saRNA — […]

January 7, 2020 - 2 minutesmins - By Jonathan Smith

In Depth 7 Jan 2020

A Different Culture Shaping Synthetic Biology in Europe

Synthetic biology research is strong in Europe, but the region has much to learn from the US when it comes to commercial translation, attracting investment and liaising with regulators. Europe’s synthetic biology scene is on the cusp of maturity. European teams dominated many areas in the overgraduate category at the International Genetically Engineered Machine (iGEM) […]

January 7, 2020 - 8 minutesmins - By David Kirk

News and Trends 6 Jan 2020

BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice

A CAR T-cell therapy amplified by RNA technology, developed by BioNTech, has shown preclinical potential for tackling solid tumors, which are hard to treat with current CAR T-cell therapies. In a study published in Science, the CAR T-cell and RNA combination therapy suppressed tumors in mice implanted with human ovarian cancer for longer than regular […]

January 6, 2020 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

What’s the Secret to Making Returns in Industrial Biotech?

KaNDy’s Menopause Treatment Tackles Hot Flashes in Phase II

Eyevensys’ Gene Therapy for Blindness Boosted with €27M Series B

This Biotech Makes Easily Implantable Artificial Cornea Transplants

Emergex Vaccines Secures €10M to Advance Synthetic Vaccine Development

French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy

Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment

NorthSea Therapeutics Raises €36M to Complete NASH Phase II Trial

Update: Chinese Pharma Enlists Synaffix’s ADC Technology for Second Drug

AstraZeneca Recruits RNA Biotech to Develop Metabolic Disease Therapies

A Different Culture Shaping Synthetic Biology in Europe

BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!